However, as the components of the GALAD score are associated with late-stage HCC characteristics, including the association of DCP levels with portal vein invasion [17] and AFP-L3 levels with tumor metastasis and poor differentiation [18], its value for surveillance of early-stage HCC remains uncertain. The gene discussed is AFP; the disease is hepatocellular carcinoma.